Compare Aspen Aerogels Inc (ASPN) vs Mesoblast Limited (MESO) Price & Performance

Aspen Aerogels IncTrade

Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

Aspen Aerogels Inc vs Mesoblast Limited — how do they compare? Aspen Aerogels Inc trades at $6.15 (market cap $509.55M), while Mesoblast Limited trades at $16.68 (market cap $2.21B). The key difference: Mesoblast Limited is far larger — about 4.3× Aspen Aerogels Inc's market cap, and Aspen Aerogels Inc is trading nearer its 52-week high, Mesoblast Limited nearer its low. Which is the better fit depends on your goals.

	ASPN	MESO
Market Cap	$509.55M	$2.21B
Sector	Technology	Technology
52-Week High	$8.82	$20.96
52-Week Low	$2.57	$12.88
Enterprise Value	$482.96M	$2.21B

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASPN

Aspen Aerogels posts stronger Q2 revenue and EBITDA, signals further recovery in Q3 despite challenges.Seeking Alpha · 1 day agoNeutral Aspen Aerogels poised for growth with EV battery barriers and new material uses in data centers and grids.Seeking Alpha · 2 days agoBullish View details →

MESO

View details →

About Aspen Aerogels Inc

Aspen Aerogels is an aerogel technology company that designs high-performance insulation. Its products are used in energy infrastructure and electric vehicles to provide thermal management and fire protection.

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.